Microencapsulated Saccharomyces cerevisiae Column Bioreactor for Potential Use in Renal Failure Uremia

REFERENCES

• Zhang, Q. and Rothenbacher, D. (2008). Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health, 8: 117.
   PubMed Web of Science ®Google Scholar
• Thadhani, R., Pascual, M., Bonventre, J.V. (1996). Medical progress: Acute renal failure. N Engl J Med, 334: 1448–1460.
   PubMed Web of Science ®Google Scholar
• Lieberthal, W., Nigam, S.K. (2000). Acute renal failure. II. Experimental models acute renal failure: Imperfect but indispensable. Am J Physiol Renal Physiol, 278: F1–F12.
   PubMed Web of Science ®Google Scholar
• Nigam, S.K. and Lieberthal, W. (2000). Acute renal failure. III. The role of growth factors in the process of renal regeneration and repair. Am J Physiol Renal Physiol, 279: F3–F11.
   Web of Science ®Google Scholar
• Schrier, R.W., Wang, W. (2004). Acute renal failure and sepsis. N Engl J Med, 351: 159–69.
   PubMed Web of Science ®Google Scholar
• Han, M.K., Hyzy, R. (2006). Advances in critical care management of hepatic failure and insufficiency. Crit Care Med, 34: 225–31.
   Web of Science ®Google Scholar
• Kida, K., Nakajo, S., Kamiya, F., Toyama, Y., Nishio, T., and Nakagawa, H. (1978). Renal net glucose release in vivo and its contribution to blood glucose in rats. J Clin Investig 62: 721–726.
   PubMed Web of Science ®Google Scholar
• Tannen, R.L. and Sastrasinh, S. (1984). Response of ammonia metabolism to acute acidosis. Kidney Int, 25: 1–10.
   PubMed Web of Science ®Google Scholar
• Deneke, S.M. and Fanburg, B.L. (1989). Regulation of cellular glutathione. Am J Physiol, 257: L163–L173.
   PubMed Web of Science ®Google Scholar
• Maak, T. (1992). Renal Handling of Proteins and Polypeptides in Handbook of Physiology. New York: Oxford University Press.
   Google Scholar
• Frank, J., Engler-Blum, G., Rodemann, H.P., and Muller, G.A. (1993). Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1: 26–35.
   PubMedGoogle Scholar
• Stadnyk, A.W. (1994) Cytokine production by epithelial cells. FASEB J, 8: 1041–1047.
   PubMed Web of Science ®Google Scholar
• Bruni, S., Chang, T.M. (1991). Encapsulated hepatocytes for controlling hyperbilirubinemia in Gunn rats. Int. J. Artif. Organs, 14: 239–241.
   PubMed Web of Science ®Google Scholar
• Bruni, S., Chang, T.M. (1989). Hepatocytes immobilised by microencapsulation in artificial cells: Effects on hyperbilirubinemia in Gunn rats. Biomater. Artif. Cells Artif. Organs, 17: 403–411.
   PubMed Web of Science ®Google Scholar
• Chang, T.M. (1997). Artificial cells and bioencapsulation in bioartificial organs. Ann.N.Y.Acad.Sci, 831: 249–259.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (2001). Present status of modified hemoglobin as blood substitutes and oral therapy for end stage renal failure using artificial cells containing genetically engineered cells. Ann.N.Y.Acad.Sci, 944: 362–372.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1992). Living cells and microorganism immobilized by microencapsulation inside artificial cells. Fundamentals of Animal Cell Encapsulation and Immobilization. New York: CRC Press, 183–196.
   Google Scholar
• Chang, T.M.S. (1985). Biotechnology of artificial cells including its application in artificial organs. The Principles, Applications and Regulations of Biotechnology in Industry, Agriculture and Medicine. New York: Pergamon Press, 53–72.
   Google Scholar
• Chang, T.M.S. (1994). Artificial cell including blood substitutes and biomicroencapsulation: From ideas to applications. Blood substitutes and immbolization biotechnology. J. Artificial Cells, 22: vii–xiv.
   Google Scholar
• Friedman, E.A., Saltzman, M.J., Beyer, M.M., Josephson, A.S. (1976). Combined oxystarch-charcoal trial in uremia: Sorbent-induced reduction in serum cholesterol. Kidney Int. Suppl, S273–S276.
   Google Scholar
• Giordano, C., Esposito, R., Pluvio, M. (1976). Further studies with oxystarch. Kidney Int. Suppl, S266–S268.
   Google Scholar
• Goosen, A.M., Mattheus, F.A. (1988). Research on animal cell culture in microcapsules. Chem. Eng. Educ, 22: 196–200.
   Google Scholar
• Prakash, S., Chang, T.M.S. (1996). Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on 1. Column bioreactor and 2. Oral administration in uremic rats. Artif. Cells Blood Substit. Immobil.Biotechnol, 24: 201–218.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1964). Semipermeable microcapsules. Science, 146: 524–525.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1966). Semipermeable aqueous microcapsules (“artificial cells”) with emphasis on experiments in an extracorporeal shunt system. Trans. Am. Soc. Artif. Intern. Organs, 12: 13–19.
   PubMedGoogle Scholar
• Chang, T.M.S. (1988). Medical applications of immobilized proteins, enzymes, and cells. Methods Enzymol, 137: 444–457.
   PubMed Web of Science ®Google Scholar
• Charles, S., David, M., Stacia, M. (1998). Control of Body Fluid, Electrolyte, and Acid-base Balance in Human Physiology: Foundations and Frontiers. St. Louis, Missouri: Times-Mirror College Publications, 526–527.
   Google Scholar
• Jain, P., Shah, S., Coussa, R., Prakash S (2009). Potentials and limitations of microorganisms as renal failure biotherapeutics. Biologics: Targets and Therapy, 3: 233–243.
   PubMedGoogle Scholar
• Chang, T.M.S., Prakash, S. (1997). Microencapsulated genetically engineered microrganisms for clinical application (6217859). US. Ref Type: Patent.
   Google Scholar
• Chang, T.M.S., Loa, S.K. (1970). Urea removal by urease and ammonia absorbents in the intestine. The Physiologist, 13: 70.
   Google Scholar
• Chang, T.M.S. (1969). Removal of endogenous and exogenous toxins by a microencapsulated absorbent. Can. J. Physiol Pharmacol, 47: 1043–1045.
   PubMed Web of Science ®Google Scholar
• Prakash, S., Chang, T.M.S. (2000). In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells. Int. J. Artif. Organs, 23: 429–435.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S., Prakash, S. (1998). Therapeutic uses of microencapsulated genetically engineered cells. Mol. Med. Today, 4: 221–227.
   PubMedGoogle Scholar
• Chang, T.M.S., Malouf, C., Ressurreccion, E.N. (1979). Artificial cells containing multienzyme systems for the sequential conversion of urea into ammonia, glutamate, then alanine. Artif. Organs, 3: 284–287.
   Google Scholar
• Chang, T.M.S., Prakash, S. (1996). Methods in Molecular Biology: Recombinant Gene Expression Protocols. Humana Press, New Jersey, 343–357.
   Google Scholar
• Chow, K.M., Liu, Z.C., Prakash, S., Chang, T.M.S. (2003). Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal. Artif. Cells Blood Substit. Immobil. Biotechnol. 31: 425–434.
   Google Scholar
• Castelman, B., McNeely, B.U. (1974). Case records of the Massachusetts General Hospital. New England Journal of Medicine, 290: 39–49.
   PubMed Web of Science ®Google Scholar
• Demetriou, A.A., Whiting, J.F., Feldman, D., Levenson, S.M., Chowdhury, N.R., Moscioni, A.D., Kram, M., Chowdhury, J.R. (1986). Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science, 233: 1190–1192.
   PubMed Web of Science ®Google Scholar
• Dixit, V., Darvasi, R., Arthur, M., Brezina, M., Lewin, K., Gitnick, G. (1990). Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology, 12: 1342–1349.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1999). Future prospects for artificial blood. Trends Biotechnol, 17: 61–67.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1990). Biotechnological and medical applications based on immobilization of hepatocytes, microorganisms, or enzyme systems by microencapsulation in artificial cells. Ann. N. Y. Acad. Sci, 613: 109–115.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1992). Artificial cells: 35 years. Artif. Organs, 16: 8–12.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1980). New approaches using immobilized enzymes for the removal of urea and ammonia. Enzyme Engineering, 5: 225–229.
   Google Scholar
• Cohen, B.D. (1972), Uremic toxins. In Uremia: An International Conference on Pathogenesis, Diagnosis and Therapy, R. Kulte, B. Geoffrey, and B. C. Benjamin, Eds, Stuttgart, Germany: Thieme, 1–11.
   Google Scholar
• Friedman, E.A. (1978). Future Treatment of Renal Failure: Strategy in Renal Failure. New York: Wiley, 521–528.
   Google Scholar
• Hausinger, R.P. (2004). Metabolic versatility of prokaryotes for urea decomposition. Journal of Bacteriology, 186: 2520–2522.
   PubMed Web of Science ®Google Scholar
• Sumrada, R.A., Cooper, T.G. (1982). Urea carboxylase and allophanate hydrolase are components of a multifunctional protein in yeast. J. Biol. Chem, 257: 9119–9127.
   PubMed Web of Science ®Google Scholar
• Chang, T.M.S. (1988). Artificial cells as bioreactive biomaterials. J Biomater Appl., 3: 116–25.
   PubMedGoogle Scholar
• Jainkiatfu, K. (2005). Effects of vitamin E-coated membrane dialyzer on reduction of inflammation. Hemodialysis International, 9: 88–88.
   Google Scholar
• National Kidney and Urologic Diseases Information Clearinghouse. Kidney Failure: Choosing a Treatment That's Right for You. Aavailable at: http://kidney.niddk.nih.gov/Kudiseases/pubs/choosingtreatment/index.htm.
   Google Scholar